Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation.

Peters FS, Peeters AMA, Hofland LJ, Betjes MGH, Boer K, Baan CC.

Front Immunol. 2017 Jul 12;8:822. doi: 10.3389/fimmu.2017.00822. eCollection 2017.

2.

Predicting disease onset in clinically healthy people.

Zeliger HI.

Interdiscip Toxicol. 2016 Jun;9(2):39-54. doi: 10.1515/intox-2016-0006. Epub 2017 May 17. Review.

3.

Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers.

Park JE, Sun Y, Lim SK, Tam JP, Dekker M, Chen H, Sze SK.

Sci Rep. 2017 Jan 12;7:40569. doi: 10.1038/srep40569.

4.

Epigenetics and Cellular Metabolism.

Xu W, Wang F, Yu Z, Xin F.

Genet Epigenet. 2016 Sep 25;8:43-51. eCollection 2016. Review.

5.

Active and Repressive Chromatin-Associated Proteome after MPA Treatment and the Role of Midkine in Epithelial Monolayer Permeability.

Khan N, Lenz C, Binder L, Pantakani DV, Asif AR.

Int J Mol Sci. 2016 Apr 20;17(4). pii: E597. doi: 10.3390/ijms17040597.

6.

Childbirth and consequent atopic disease: emerging evidence on epigenetic effects based on the hygiene and EPIIC hypotheses.

Dahlen HG, Downe S, Wright ML, Kennedy HP, Taylor JY.

BMC Pregnancy Childbirth. 2016 Jan 13;16:4. doi: 10.1186/s12884-015-0768-9.

7.

Epigenetics across the human lifespan.

Kanherkar RR, Bhatia-Dey N, Csoka AB.

Front Cell Dev Biol. 2014 Sep 9;2:49. doi: 10.3389/fcell.2014.00049. eCollection 2014. Review.

8.

Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases.

Qureshi IA, Mehler MF.

Neurotherapeutics. 2014 Oct;11(4):708-20. doi: 10.1007/s13311-014-0302-1. Review.

9.

From attention to memory along the dorsal-ventral axis of the medial prefrontal cortex: some methodological considerations.

Cassaday HJ, Nelson AJ, Pezze MA.

Front Syst Neurosci. 2014 Sep 8;8:160. doi: 10.3389/fnsys.2014.00160. eCollection 2014. Review.

10.
11.

Clinical applications of epigenetics in cardiovascular disease: the long road ahead.

Aslibekyan S, Claas SA, Arnett DK.

Transl Res. 2015 Jan;165(1):143-53. doi: 10.1016/j.trsl.2014.04.004. Epub 2014 Apr 8. Review.

12.

Epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders.

Kubota T, Takae H, Miyake K.

Pharmaceuticals (Basel). 2012 Apr 5;5(4):369-83. doi: 10.3390/ph5040369.

13.
14.

Epigenetics, nervous system tumors, and cancer stem cells.

Qureshi IA, Mehler MF.

Cancers (Basel). 2011 Sep 13;3(3):3525-56. doi: 10.3390/cancers3033525.

15.

Developing epigenetic diagnostics and therapeutics for brain disorders.

Qureshi IA, Mehler MF.

Trends Mol Med. 2013 Dec;19(12):732-41. doi: 10.1016/j.molmed.2013.09.003. Epub 2013 Oct 18. Review.

16.

Gut indigenous microbiota and epigenetics.

Shenderov BA.

Microb Ecol Health Dis. 2012 Mar 28;23. doi: 10.3402/mehd.v23i0.17195. eCollection 2012.

17.

Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.

Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D.

J Clin Invest. 2013 Aug;123(8):3552-63. doi: 10.1172/JCI65636. Epub 2013 Jul 25.

18.

Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects.

Ghosh SK, McCormick TS, Eapen BL, Yohannes E, Chance MR, Weinberg A.

Epigenetics. 2013 Jul;8(7):703-9. doi: 10.4161/epi.25028. Epub 2013 May 17.

19.

Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.

Adwan L, Zawia NH.

Pharmacol Ther. 2013 Jul;139(1):41-50. doi: 10.1016/j.pharmthera.2013.03.010. Epub 2013 Apr 3. Review.

20.

Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke.

Kalani A, Kamat PK, Tyagi SC, Tyagi N.

Mol Neurobiol. 2013 Aug;48(1):157-68. doi: 10.1007/s12035-013-8421-y. Epub 2013 Feb 22. Review.

Supplemental Content

Support Center